Literature DB >> 28246059

Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist's jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS?

Patrick W Serruys1, Yoshinobu Onuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28246059     DOI： 10.4244/EIJY17M02_01

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  5 in total

1.  Bioresorbable scaffolds versus metallic stents in routine PCI: the plot thickens.

Authors:  Athanasios Katsikis; Patrick W Serruys
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Healing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomes.

Authors:  Xucheng Lv; Li Shen; Yizhe Wu; Lei Ge; Jiahui Chen; Jiasheng Yin; Rui Wang; Meng Ji; Bin Hong; Junbo Ge
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-28       Impact factor: 2.357

3.  Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions.

Authors:  Emil Nielsen Holck; Camilla Fox-Maule; Trine Ørhøj Barkholt; Lars Jakobsen; Shengxian Tu; Michael Maeng; Jouke Dijkstra; Evald Høj Christiansen; Niels Ramsing Holm
Journal:  Int J Cardiovasc Imaging       Date:  2019-05-04       Impact factor: 2.357

4.  Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients.

Authors:  Beytullah Cakal; Sinem Cakal; Oguz Karaca; Mehmet Onur Omaygenc; Filiz Kizilirmak Yilmaz; Haci Murat Gunes; Ozgur Ulas Ozcan; Arzu Yıldırım; Bilal Boztosun
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

5.  Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials.

Authors:  Alexander N Kharlamov
Journal:  World J Cardiol       Date:  2018-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.